Info Edge (India) Limited Board Approves Q3 FY2026 Results and Second Interim Dividend

Info Edge (India) Limited announced the outcome of its Board meeting held on February 13, 2026. The Board approved the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. Key decisions included the declaration of a Second Interim Dividend of ₹2.40 per share for FY 2025-26, and amendments to the Dividend Distribution Policy. Standalone revenue grew 11.8% YoY, with operating margins improving to 38.9%.

Board Meeting Outcomes: February 13, 2026

The Board of Directors of Info Edge (India) Limited, following their meeting on Friday, February 13, 2026, approved several key items of business, primarily focusing on financial disclosures and corporate actions.

Unaudited Financial Results (Q3 FY2026)

The Board approved and took on record the unaudited Standalone & Consolidated Financial Results for the quarter and the nine months ended December 31, 2025. These results, along with the Limited Review Reports, have been duly enclosed as part of the regulatory filing.

Standalone Performance Highlights (Q3FY26)

  • Billings: Rs. 747 crore (YoY growth of +11.8%).
  • Revenue from Operations: Rs. 765 crore (YoY growth of +13.9%).
  • Operating Profit: Rs. 297 crore (YoY growth of +12.9%).
  • Operating Profit Margin: 38.9%.
  • Cash from Operations (before Taxes): Rs. 376 crore (YoY growth of +8.8%).
  • Earnings per share (before exceptional items): Rs. 4.37 (YoY growth of +8.9%).
  • Cash Balance: Rs. 4,825 crore as of December 31, 2025 (Standalone, including wholly owned subsidiaries).

Key Operational Highlights for Standalone Business (Q3FY26)

The quarter demonstrated steady business growth and improved operating profitability. A key highlight was the 303 basis point QoQ improvement in standalone operating profit margins.

The Recruitment business (Naukri) saw billings grow by 11% YoY, while non-recruitment segments (99acres, Jeevansathi, Shiksha) combined grew at 14.1% in billings. The Naukri database reached 113 million resumes, with 20k+ resumes added daily.

99Acres reported billings growth of 14.5% in Q3, with traffic time share increasing to 46%. The Jeevansathi matrimony business maintained strong momentum with 29%+ YoY billings growth.

Second Interim Dividend Declared

The Board has declared the 2nd Interim Dividend for the financial year 2025-26 at the rate of Rs. 2.40/- per share (on a face value of Rs.2/- per share). The record date for eligibility is set as Friday, February 20, 2026, with payment scheduled on or after March 9, 2026.

Dividend Distribution Policy Amended

Amendments to the Dividend Distribution Policy of the Company were also approved based on the recommendation of the Stakeholders Relationship Committee. The amended policy is effective from February 13, 2026.

Consolidated Performance Summary (Q3FY26)

At the consolidated level, net sales stood at Rs. 819.4 crore in Q3FY26 versus Rs. 722.4 crore for Q3FY25. Profit before tax (without exceptional items) was Rs 444.7 crore. However, the total comprehensive loss was Rs. 3,954.6 crore in Q3FY26, compared to an income of Rs. 3,182.4 crore in Q3FY25, largely influenced by significant movements in other comprehensive income.

Investment Portfolio Status (As of Dec 31, 2025)

The balance sheet includes 21 active financial investments in unlisted entities, with a total carrying value of Rs. 654 crore. Listed investments include Eternal and PB Fintech, each valued at approximately Rs. 146.5 crore and Rs. 575.8 crore respectively, representing 12.43% shareholding in both.

Balance Sheet Snapshot (Standalone as of Dec 31, 2025)

Total Assets stood at Rs. 47,674 crore. The asset mix is predominantly 89.2% in Investments, with 7.3% in Cash & Cash Equivalents. On the liabilities side, 85.1% is attributed to Shareholder’s Equity.

Source: BSE

Previous Article

Eris Lifesciences Limited Board Approves Q3 FY2025-26 Unaudited Financial Results

Next Article

PG Electroplast Limited Monitoring Agency Report for Q3 FY2025-26 Proceeds Utilization